 | • レポートコード：D0FB0646448 • 出版社/出版日：Prof Research / 2019年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：製薬・医療 |
| Single User | ￥420,000 (USD3,000) | ▷ お問い合わせ |
| Site License | ￥532,000 (USD3,800) | ▷ お問い合わせ |
| Global Site License | ￥700,000 (USD5,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 慢性蕁麻疹/蕁麻疹薬のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は慢性蕁麻疹/蕁麻疹薬の市場概要、産業チェーン、市場動向、市場規模予測、需要先情報、関連企業情報などを収録しており、アジアにおける慢性蕁麻疹/蕁麻疹薬市場の詳細な情報を探している方にとって有用な参考資料です。日本、中国、インド、韓国、インドネシア、マレーシア、フィリピン、タイ、ベトナム、シンガポール、オーストラリアなどを地域を対象にしています。 ・市場概要 ・産業チェーン分析（ファイブフォース分析、コスト構造分析） ・市場動向 ・慢性蕁麻疹/蕁麻疹薬のアジア市場規模推移2014-2019 ・慢性蕁麻疹/蕁麻疹薬のアジア市場規模予測2019-2024 ・慢性蕁麻疹/蕁麻疹薬のサプライヤー分析 ・顧客（需要先）分析 ・主要企業分析（AstraZeneca Plc、Biofrontera AG、ELORAC、Inc.、Faes Farma、SA、Genentech、Inc.、GlaxoSmithKline Plc、J Uriach Y Compania、S.A.、Mabtech Limited、Merck& Co.、Inc.、Mycenax Biotech Inc.、Novartis AG、Pa） ・結論 |
Abstract:
The Asia Pacific Chronic Urticaria Or Hives Drug market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024.
This report is an essential reference for who looks for detailed information on Asia Pacific Chronic Urticaria Or Hives Drug market. The report covers data on Asia Pacific markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Asia Pacific major vendors¡¯ information. In addition to the data part, the report also provides overview of Chronic Urticaria Or Hives Drug market, including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user’s requirements is also available.
Key Points of this Report:
* The depth industry chain include analysis value chain analysis, porter five forces model analysis and cost structure analysis
* The report covers Asia Pacific and country-wise market of Chronic Urticaria Or Hives Drug
* It describes present situation, historical background and future forecast
* Comprehensive data showing Chronic Urticaria Or Hives Drug capacities, production, consumption, trade statistics, and prices in the recent years are provided
* The report indicates a wealth of information on Chronic Urticaria Or Hives Drug manufacturers
* Chronic Urticaria Or Hives Drug market forecast for next five years, including market volumes and prices is also provided
* Raw Material Supply and Downstream Consumer Information is also included
* Any other user’s requirements which is feasible for us
The largest vendors of Asia Pacific Chronic Urticaria Or Hives Drug market: (At least 14 companies included)
* AstraZeneca Plc
* Biofrontera AG
* ELORAC
* Faes Farma
* SA
* Genentech
For complete list, please ask for sample pages.
The Chronic Urticaria Or Hives Drug market in Asia Pacific is segmented by countries:
* China
* India
* Japan
* South Korea
* Bangladesh
* Sri Lanka
* Indonesia
* Malaysia
* Philippines
* Thailand
* Vietnam
* Singapore
* Australia
* New Zealand
The reports analysis Chronic Urticaria Or Hives Drug market in Asia Pacific by products type:
* Type I
* Type II
* Type III
The reports analysis Chronic Urticaria Or Hives Drug market in Asia Pacific by application as well:
* Application I
* Application II
* Application III
Reasons to Purchase this Report:
* Analyzing the outlook of the market with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Distribution Channel sales Analysis by Value
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.
Any special requirements about this report, please let us know and we can provide custom report.
レポート目次Table of Contents
Chapter One Chronic Urticaria Or Hives Drug Overview
1.1 Chronic Urticaria Or Hives Drug Outline
1.2 Classification and Application
1.3 Manufacturing Technology
Chapter Two Industry Chain Analysis
2.1 Value Chain Analysis
2.2 Porter Five Forces Model Analysis
2.3 Cost Structure Analysis
Chapter Three Market Dynamics of Chronic Urticaria Or Hives Drug Industry
3.1 Latest News and Policy
3.2 Market Drivers
3.3 Market Challenges
Chapter Four Asia Pacific Market of Chronic Urticaria Or Hives Drug (2014-2019)
4.1 Chronic Urticaria Or Hives Drug Supply
4.2 Chronic Urticaria Or Hives Drug Market Size
4.3 Import and Export
4.4 Demand Analysis
4.5 Market Competition Analysis
4.6 Price Analysis
4.7 Country-wise Analysis
Chapter Five Asia Pacific Market Forecast (2019-2024)
5.1 Chronic Urticaria Or Hives Drug Supply
5.2 Chronic Urticaria Or Hives Drug Market Size
5.3 Import and Export
5.4 Demand Analysis
5.5 Market Competition Analysis
5.6 Price Analysis
5.7 Country-wise Analysis
Chapter Six Asia Pacific Raw Material Supply Analysis
6.1 Raw Material Supply
6.2 Raw Material Producers Analysis
6.3 Analysis of the Influence of Raw Material Price Fluctuation
Chapter Seven Asia Pacific Chronic Urticaria Or Hives Drug Consumer Analysis
7.1 Asia Pacific Major Consumers Information
7.2 Asia Pacific Major Consumer Demand Analysis
Chapter Eight Analysis of Asia Pacific Key Manufacturers (Including Company Profile, SWOT Analysis, Production Information etc.)
8.1 AstraZeneca Plc
8.2 Biofrontera AG
8.3 ELORAC
8.4 Faes Farma
8.5 SA
……
……
Chapter Nine Research Conclusions of Asia Pacific Chronic Urticaria Or Hives Drug Industry
Tables and Figures
Figure Commercial Product of Chronic Urticaria Or Hives Drug
Table Classification of Chronic Urticaria Or Hives Drug
Table Application of Chronic Urticaria Or Hives Drug
Figure Porter Five Forces Model Analysis of Asia Pacific Chronic Urticaria Or Hives Drug
Figure Production Cost Analysis of Asia Pacific Chronic Urticaria Or Hives Drug
Table Chronic Urticaria Or Hives Drug Market Drivers & Market Challenges
Table 2014-2019 Asia Pacific Chronic Urticaria Or Hives Drug Capacity List
Table 2014-2019 Asia Pacific Chronic Urticaria Or Hives Drug Key Manufacturers Capacity Share List
Figure 2014-2019 Asia Pacific Chronic Urticaria Or Hives Drug Key Manufacturers Capacity Share
Table 2014-2019 Asia Pacific Chronic Urticaria Or Hives Drug Key Manufacturers Production List
Table 2014-2019 Asia Pacific Chronic Urticaria Or Hives Drug Key Manufacturers Production Share List
Figure 2014-2019 Asia Pacific Chronic Urticaria Or Hives Drug Key Manufacturers Production Share
Figure 2014-2019 Asia Pacific Chronic Urticaria Or Hives Drug Capacity Production and Growth Rate
Table 2014-2019 Asia Pacific Chronic Urticaria Or Hives Drug Key Manufacturers Production Value (Million USD) List
Figure 2014-2019 Asia Pacific Chronic Urticaria Or Hives Drug Production Value and Growth Rate
Table 2014-2019 Asia Pacific Chronic Urticaria Or Hives Drug Key Manufacturers Production Value Share List
Figure 2014-2019 Asia Pacific Chronic Urticaria Or Hives Drug Key Manufacturers Production Value Share List
Table 2014-2019 Asia Pacific Supply and Consumption of Chronic Urticaria Or Hives Drug
Table 2014-2019 Asia Pacific Import and Export of Chronic Urticaria Or Hives Drug
Table 2014-2019 Asia Pacific Chronic Urticaria Or Hives Drug Demand List by Application
Figure 2014-2019 Asia Pacific Chronic Urticaria Or Hives Drug Demand by Application
Table 2014-2019 Asia Pacific Chronic Urticaria Or Hives Drug Demand Share List by Application
Figure 2014-2019 Asia Pacific Chronic Urticaria Or Hives Drug Demand Share by Application
Table 2014-2019 Asia Pacific Chronic Urticaria Or Hives Drug Country-wise Consumption List
Figure 2014-2019 Asia Pacific Chronic Urticaria Or Hives Drug Country-wise Consumption
Table 2014-2019 Asia Pacific Chronic Urticaria Or Hives Drug Country-wise Consumption Share List
Figure 2014-2019 Asia Pacific Chronic Urticaria Or Hives Drug Country-wise Consumption Share
Table 2014-2019 Asia Pacific Chronic Urticaria Or Hives Drug Capacity Production Cost Profit and Gross Margin List
Table 2019-2024 Asia Pacific Chronic Urticaria Or Hives Drug Capacity List
Table 2019-2024 Asia Pacific Chronic Urticaria Or Hives Drug Key Manufacturers Capacity Share List
Figure 2019-2024 Asia Pacific Chronic Urticaria Or Hives Drug Key Manufacturers Capacity Share
Table 2019-2024 Asia Pacific Chronic Urticaria Or Hives Drug Key Manufacturers Production List
Table 2019-2024 Asia Pacific Chronic Urticaria Or Hives Drug Key Manufacturers Production Share List
Figure 2019-2024 Asia Pacific Chronic Urticaria Or Hives Drug Key Manufacturers Production Share
Figure 2019-2024 Asia Pacific Chronic Urticaria Or Hives Drug Capacity Production and Growth Rate
Figure 2019-2024 Asia Pacific Chronic Urticaria Or Hives Drug Production Value and Growth Rate
Table 2019-2024 Asia Pacific Supply and Consumption of Chronic Urticaria Or Hives Drug
Table 2019-2024 Asia Pacific Import and Export of Chronic Urticaria Or Hives Drug
Table 2019-2024 Asia Pacific Demand of Chronic Urticaria Or Hives Drug by Application
Figure 2019-2024 Asia Pacific Chronic Urticaria Or Hives Drug Demand by Application
Table 2019-2024 Asia Pacific Chronic Urticaria Or Hives Drug Demand Share List by Application
Figure 2019-2024 Asia Pacific Chronic Urticaria Or Hives Drug Demand Share by Application
Table 2019-2024 Asia Pacific Chronic Urticaria Or Hives Drug Country-wise Consumption List
Figure 2019-2024 Asia Pacific Chronic Urticaria Or Hives Drug Country-wise Consumption
Table 2019-2024 Asia Pacific Chronic Urticaria Or Hives Drug Country-wise Consumption Share List
Figure 2019-2024 Asia Pacific Chronic Urticaria Or Hives Drug Country-wise Consumption Share
Table 2019-2024 Asia Pacific Chronic Urticaria Or Hives Drug Capacity Production Cost Profit and Gross Margin List
Table Asia Pacific Chronic Urticaria Or Hives Drug Raw Material Suppliers
Table Key End Users List
Table Profile of AstraZeneca Plc
Table SWOT Analysis of AstraZeneca Plc
Table AstraZeneca Plc Chronic Urticaria Or Hives Drug Product Specification
Table 2014-2019 AstraZeneca Plc Chronic Urticaria Or Hives Drug Product Capacity Production Price Cost Production Value List
Figure 2014-2019 AstraZeneca Plc Chronic Urticaria Or Hives Drug Capacity Production and Growth Rate
Figure 2014-2019 AstraZeneca Plc Chronic Urticaria Or Hives Drug Production Global Market Share
Table SWOT Analysis of Biofrontera AG
Figure Biofrontera AG Chronic Urticaria Or Hives Drug Products
Table 2014-2019 Biofrontera AG Chronic Urticaria Or Hives Drug Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Biofrontera AG Chronic Urticaria Or Hives Drug Capacity Production and Growth Rate
Figure 2014-2019 Biofrontera AG Chronic Urticaria Or Hives Drug Production Global Market Share
Table SWOT Analysis of ELORAC
Figure ELORAC Chronic Urticaria Or Hives Drug Product
Table ELORAC Chronic Urticaria Or Hives Drug Product Specification
Table 2014-2019 ELORAC Chronic Urticaria Or Hives Drug Product Capacity Production Price Cost Production Value List
Figure 2014-2019 ELORAC Chronic Urticaria Or Hives Drug Capacity Production and Growth Rate
Figure 2014-2019 ELORAC Chronic Urticaria Or Hives Drug Production Global Market Share
Table Profile of Faes Farma
Table SWOT Analysis of Faes Farma
Figure Faes Farma Chronic Urticaria Or Hives Drug Product
Table Faes Farma Chronic Urticaria Or Hives Drug Product Specification
Table 2014-2019 Faes Farma Chronic Urticaria Or Hives Drug Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Faes Farma Chronic Urticaria Or Hives Drug Capacity Production and Growth Rate
Figure 2014-2019 Faes Farma Chronic Urticaria Or Hives Drug Production Global Market Share
Table Profile of SA
Table SWOT Analysis of SA
Figure SA Chronic Urticaria Or Hives Drug Product
Table 2014-2019 SA Chronic Urticaria Or Hives Drug Product Capacity Production Price Cost Production Value List
Figure 2014-2019 SA Chronic Urticaria Or Hives Drug Capacity Production and Growth Rate
Figure 2014-2019 SA Chronic Urticaria Or Hives Drug Production Global Market Share
……
……
慢性炎症性脱髄性多発神経障害薬のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Chronic Inflammatory Demyelinating Polyneuropathy Drug market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who …- 慢性腎臓病（CKD）のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Chronic Kidney Disease (CKD) market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detailed informa…
- 慢性特発性骨髄線維症のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Chronic Idiopathic Myelofibrosis market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detailed inf…
- 慢性閉塞性肺疾患のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Chronic Obstructive Pulmonary Disease market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detaile…
- 慢性ドレナージカテーテルのアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Chronic Drainage Catheters market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detailed informati…